Article (Scientific journals)
Treatment of mucocutaneous presentations of herpes simplex virus infections.
Nikkels, Arjen; Pierard, Gérald
2002In American Journal of Clinical Dermatology, 3 (7), p. 475-87
Peer Reviewed verified by ORBi
 

Files


Full Text
TREATMENT MUCOCUTANEOUS.pdf
Publisher postprint (592.97 kB)
Request a copy

All documents in ORBi are protected by a user license.

Send to



Details



Keywords :
Acantholysis/drug therapy; Antiviral Agents/therapeutic use; Burns/complications; Erythema Multiforme/virology; Herpes Genitalis/drug therapy; Herpes Labialis/drug therapy; Herpes Simplex/drug therapy/etiology; Humans; Infant, Newborn; Infant, Newborn, Diseases/drug therapy; Postoperative Complications; Recurrence; Skin/injuries; Ultraviolet Rays/adverse effects
Abstract :
[en] Infections by herpes simplex virus (HSV) types I and II are diverse and quite frequent. After primary infection, the virus establishes a life-long latency in the sensory ganglia and recrudescences may occur at an unpredictable rate. Recurrent labial and genital herpes infections represent the majority of clinical manifestations of HSV infections. Their management is currently well established using evidence-based medicine data. Primary labial herpes is generally not treated with antivirals in otherwise healthy children, although intravenous aciclovir may be offered in severe primary infections, particularly in the immunocompromised patient. The decision whether or not to treat recurrent labial herpes should be evaluated individually and depends on the frequency and severity of relapses, the impairment of the quality of life, and the cost of therapy. Patients with mild disease may benefit from topical therapy, and those with severe and frequent recurrences may be considered for intermittent or long-term oral antiviral therapy. Primary genital herpes is treated with oral or intravenous antivirals, depending on the severity of the infection and associated symptoms. Recurrent genital herpes can be managed with episodic short courses of oral antivirals in patients whose recurrences are moderate to severe and rare, and have a clear prodrome. Patients with >5 episodes/year, severe recurrences or unrecognisable prodromes may be best managed with long-term suppressive antiviral prophylaxis. HSV is also responsible for a variety of other clinical manifestations, including herpetic whitlow, neonatal infection, disseminated and atypical cutaneous infections, traumatic herpes, eczema herpeticum, and HSV-associated erythema multiforme. HSV infection may also represent a complication following cosmetic procedures of the oro-facial region, surgical and dental interventions, sun exposure and burns. Precise treatment guidelines for these HSV infections are not firmly established.
Disciplines :
Dermatology
Author, co-author :
Nikkels, Arjen ;  Université de Liège - ULiège > Dermatologie
Pierard, Gérald ;  Université de Liège - ULiège > Dermatopathologie
Language :
English
Title :
Treatment of mucocutaneous presentations of herpes simplex virus infections.
Publication date :
2002
Journal title :
American Journal of Clinical Dermatology
ISSN :
1175-0561
eISSN :
1179-1888
Publisher :
Adis International, Auckland, New Zealand
Volume :
3
Issue :
7
Pages :
475-87
Peer reviewed :
Peer Reviewed verified by ORBi
Available on ORBi :
since 25 March 2009

Statistics


Number of views
114 (5 by ULiège)
Number of downloads
3 (2 by ULiège)

Scopus citations®
 
53
Scopus citations®
without self-citations
41
OpenCitations
 
45

Bibliography


Similar publications



Contact ORBi